Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA advisory committee
Pharma
Novo Nordisk's weekly insulin will get FDA adcomm review
The FDA will convene a panel of experts on May 24 to provide guidance on Novo Nordisk's application for once-weekly insulin Awiqli (icodec).
Kevin Dunleavy
Apr 29, 2024 11:08am
FDA advisers back new endpoint for myeloma approvals
Apr 12, 2024 4:06pm
FDA review bodes well for MRD-based myeloma approvals
Apr 10, 2024 11:30am
FDA weighs another approvable myeloma endpoint. What's at stake?
Apr 9, 2024 9:00am
Novo, Novartis, Merck KGaA, Kyowa Kirin—Fierce Pharma Asia
Mar 22, 2024 8:45am
UPDATED: FDA advisers back Carvykti, Abecma in earlier myeloma
Mar 15, 2024 1:58pm